Bayer, J&J settle U.S. Xarelto litigation for $775 million

March 25, 2019

(Reuters) – Bayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsuits over their blockbuster blood thinner Xarelto for a total of $775 million, court documents on Monday showed.

The amount will be shared equally between the two companies that jointly developed the drug. Bayer and J&J do not admit liability under the agreement.

(Reporting by Tina Bellon in New York; Editing by Bill Berkrot)

Comments (No)

Leave a Reply